Trading window closed from Oct 1 ahead of Q2 results

Compliance View source PDF Explain this filing

AKUMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.2%Reaction day

₹819.70

prior close

₹819.55

announcement price

After-mkt

timing

Nifty Microcap 250market-1.6%-0.6% vs market

Pharmaceuticals peers, median of 172sector-1.5%-0.7% vs sector

On the reaction day the stock moved 0.6 pts less than Nifty Microcap 250 and 0.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.1

10m

-1.2

15m

-1.4

30m

-1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.2-1.6-0.6-1.5-0.7

Next day

-0.1-0.6+0.5-1.0+0.9

-0.7-0.8+0.1-1.9+1.2

-0.5-2.1+1.6-2.5+2.0

-2.6-2.1-0.5-3.4+0.7

-0.4-0.8+0.4-2.4+2.0

-4.2-3.8-0.5-4.3+0.0

15d

-15.6-6.9-8.7-7.8-7.7

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Akums Drugs and Pharmaceuticals has informed exchanges that the trading window for insiders and their immediate relatives will be closed from October 1, 2026 until 48 hours after the declaration of unaudited standalone and consolidated financial results for the quarter ending September 30, 2026. The board meeting date to approve these Q2 results will be announced later. This is a standard SEBI insider trading compliance filing.

Likely market impact

Routine regulatory disclosure. No price impact expected, but signals upcoming Q2 results announcement.